Introduction
Dopamine is the major neurotransmitter of the neuronal network in the human brain and is involved in the control of motor function, cognition, and behavior. [1] [2] The human dopamine transporter (SLC6A3) is a member of the sodium and chloride-dependent neurotransmitter transporter family and contains 12 transmembrane domains. [3, [4] [5] [6] [7] [8] The dopamine transporter terminates the synaptic transmission by the rapid and specifi c reuptake of dopamine into the presynaptic nerve terminals. [1, [9] [10] [11] [12] Psychostimulants, such as cocaine and amphetamine, are known to bind the dopamine transporter and inhibit dopamine reuptake. [13] In DAT knockout mice, dopamine clearance is prolonged and the mice show spontaneous hyperactivity. [14] [15] [16] [17] [18] The reduction in dopamine reuptake results in adaptive changes such as a decreased content of dopamine in presynaptic terminals and signifi cant downregulation of D1 and D2 receptor expression. [6] The dopamine hypothesis of psychosis is a model attributing symptoms of schizophrenia to a disturbed and hyperactive dopaminergic signal transduction. [7, 8] However, several reports suggested strong association between SLC6A3 gene variants and schizophrenia. [6, 9] It has further been shown that the most variants in this gene are located within the putative binding site for transcription factors. The allelic variants would also impact the nature of these response elements. [19] [20] [21] [22] To date, some single nucleotide polymorphisms have been identifi ed in the core promoter of the SLC6A3 gene, which appear to be linked with the outcome of schizophrenia. One of these variants is the T-67A polymorphism, and has previously been investigated by Khodayari et al. in a set of Iranian subjects and controls. Their fi ndings provided tentative evidence for the contribution of SlC6A3 gene core promoter polymorphism to the etiology of schizophrenia in the Iranian population. [20] We attempted also to investigate in a case-control study, the relevance of the G-660C polymorphism, in the Iranian population. 
Materials and Methods

Subject
Statistical analysis
The Chi-square test was performed to compare genotypes within and between genders. Chi-square tests were calculated using the SPSS 13 statistical package.
Results
The study of socio-demographic features of the cohort identifi ed that subjects in the case group were signifi cantly lower than those in the control group in terms of marital status and educational level (P<0.05). Control and patient groups were initially classifi ed only by gender and were not statistically different in terms of their sociodemographic features (P>0.05) [ Table 1 ]. The genotypic frequencies of individuals from the 2 geographical regions (south and south-west Iran) were GG 100%, GC 0%, CC 0%, respectively [ Table 2 ]. However, no C allele has been seen among the case-control groups.
Discussion
The relevance of genetic factors in the etiology of schizophrenia has been demonstrated in many studies, [3] and the hypoexpression of SLC6A3 has been hypothesized as a possible etiology of schizophrenia. [6] Dysregulation of hSLC6A3 expression could be related to a particular contribution of polymorphisms across the gene. [20] [21] [22] The SLC6A3 promoter region displayed 5 polymorphic sites: T-67A, G-660C, C-839T, C-1169G, and T-1476G. They are located within a core region that regulates the activity of luciferase construct with 10-150 times more activity than promoter less construct.
Computational analysis of G-660C SNP revealed that this polymorphism is located within a putative Sp1-binding site, and -660C introduces a LF-A1 binding site.
Whereas Sp1-binding site are ubiquitously expressed in mammalian cells, the transcription factor LF-A1
interacts with the promoter region of several genes expressed in hepatocytes. [22] Indeed, the functional data about the mentioned SNPs make them attractive to be involved in the etiology of schizophrenia and so far association studies. However, in 2004, Khodayari et al. carried out an association study in a cohort of Iranian subjects and controls. They have found an association between the SLC6A3 gene core promoter polymorphism -67A/T and schizophrenia. [20] In the present survey, the polymorphism -660G/C was proved in a case/control study in a relatively large size of samples. Our results revealed lack of association between this polymorphism and schizophrenia disorder. Studies about European populations showed similar results. [21, 22] But, in contrast to the previous reports, the present study indicates defi nitely the lack of C allele in 400 individuals of population from south and south-west of Iran. In 800 screened alleles, the G allele was the only one that was observed. The highlight of our results is also the absence of C allele in the gene pool of Iranian population that we studied.
Therefore, this polymorphism may not have any role in pathophysiology of schizophrenia, and the -660G/C variant of SLC6A3 gene seems to be not proper candidate for etiology of schizophrenia, at least in Iranian patients.
